Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC)
- PMID: 15219235
- PMCID: PMC459521
- DOI: 10.1186/1479-5876-2-23
Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC)
Abstract
Epithelial ovarian cancer (EOC) is a significant cause of cancer related morbidity and mortality in women. Preferential involvement of peritoneal structures contributes to the overall poor outcome in EOC patients. Advances in biotechnology, such as cDNA microarray, are a product of the Human Genome Project and are beginning to provide fresh opportunities to understand the biology of EOC. In particular, it is now possible to examine in depth, at the molecular level, the complex relationship between the tumor itself and its surrounding microenvironment.This review focuses on the anatomy, physiology, and current immunobiologic research of peritoneal structures, and addresses certain potentially useful animal models. Changes in both the inflammatory and non-inflammatory cell compartments, as well as alterations to the extracellular matrix, appear to be signal events that contribute to the remodeling effects of the peritoneal stroma and surface epithelial cells on tumor growth and spread. These alterations may involve a number of proteins, including cytokines, chemokines, growth factors, either membrane or non-membrane bound, and integrins. Interactions between these molecules and molecular structures within the extracellular matrix, such as collagens and the proteoglycans, may contribute to a peritoneal mesothelial surface and stromal environment that is conducive to tumor cell proliferation and invasion. These alterations need to be examined and defined as possible prosnosticators and as therapeutic or diagnostic targets.
Figures


Similar articles
-
Ovarian cancer, the coagulation pathway, and inflammation.J Transl Med. 2005 Jun 21;3:25. doi: 10.1186/1479-5876-3-25. J Transl Med. 2005. PMID: 15969748 Free PMC article.
-
The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer.Cancers (Basel). 2018 Jul 30;10(8):251. doi: 10.3390/cancers10080251. Cancers (Basel). 2018. PMID: 30061485 Free PMC article. Review.
-
Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer.Exp Cell Res. 2015 Sep 10;337(1):16-27. doi: 10.1016/j.yexcr.2015.07.020. Epub 2015 Jul 21. Exp Cell Res. 2015. PMID: 26209607
-
Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.Int J Cancer. 2015 Jul 15;137(2):289-98. doi: 10.1002/ijc.29385. Epub 2014 Dec 18. Int J Cancer. 2015. PMID: 25482018
-
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review.
Cited by
-
The role of nanomaterials in enhancing natural product translational potential and modulating endoplasmic reticulum stress in the treatment of ovarian cancer.Front Pharmacol. 2022 Oct 26;13:987088. doi: 10.3389/fphar.2022.987088. eCollection 2022. Front Pharmacol. 2022. PMID: 36386196 Free PMC article. Review.
-
Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.Neoplasia. 2013 Apr;15(4):409-20. doi: 10.1593/neo.121228. Neoplasia. 2013. PMID: 23555186 Free PMC article.
-
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.J Clin Med. 2020 Sep 14;9(9):2967. doi: 10.3390/jcm9092967. J Clin Med. 2020. PMID: 32937961 Free PMC article. Review.
-
Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.Exp Suppl. 2022;113:1-57. doi: 10.1007/978-3-030-91311-3_1. Exp Suppl. 2022. PMID: 35165859
-
Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis.Cancers (Basel). 2019 Oct 21;11(10):1608. doi: 10.3390/cancers11101608. Cancers (Basel). 2019. PMID: 31640297 Free PMC article. Review.
References
-
- Tuhkanen H, Anttila M, Kosma V-M, Yla-Herttuala S, Heinonen S, Kuronen A, Juhola M, Tammi R, Tammi M, Mannermaa A. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3P. Int J Cancer. 2004;109:247–252. doi: 10.1002/ijc.11733. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources